25-Hydroxyvitamin D 3 -1␣-Hydroxylase Is Expressed in Human Vascular Smooth Muscle Cells and Is Upregulated by Parathyroid Hormone and Estrogenic Compounds
T here is growing interest in the potential role of vitamin D metabolites in the vasculature. Both endothelial cells and vascular smooth muscle cells (VSMCs) express high-affinity receptors for 1,25(OH) 2 vitamin D 3 , 1,2 and vitamin D metabolites exert numerous effects in VSMCs [3] [4] [5] [6] [7] [8] [9] [10] that involve vital aspects of VSMC function and pathology, including contractility, growth and migration, and the evolution of vascular calcifications. Vitamin D metabolites appear to enhance the expression of Ca-ATPase, 3 increase the entry of calcium into the cell, 4 raise cytosolic free calcium, 5 induce the expression of contractile proteins, 6 and accelerate the formation of prostacyclin 7 in VSMCs, all of which may directly or indirectly affect arterial tone. Evidence also suggests that 1,25(OH) 2 vitamin D 3 inhibits VSMC replication 8, 9 and diminishes the mitogenic response to growth enhancers such as thrombin or platelet-derived growth factor (PDGF). 9 On the other hand, 1,25(OH) 2 vitamin D 3 may accelerate cell migration 10 and promote the transition of contractile VSMCs into a secretory cell phenotype. 11 Finally, 1,25(OH) 2 D 3 has been linked to the formation of arterial calcifications in a complex and poorly understood manner; although hypervitaminosis D induces vascular calcifications 12, 13 and 1, 25(OH) 2 vitamin D 3 increases the expression of bone proteins such as osteopontin in VSMCs, 10, 13 coronary calcifications appear to be inversely related to circulating 1,25(OH) 2 vitamin D 3 . 14 Furthermore, a consistent association between osteoporosis and vascular calcification has been noted in a number of reports. 15, 16 
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Although it is possible that all the aforementioned interactions between 1,25(OH) 2 D 3 and the vasculature are exerted exclusively via the active form of the circulating vitamin, the scope of the induced effects of 1,25(OH) 2 vitamin D 3 and their potential significance for vascular function and structure are large enough to raise the possibility that an intracellularly produced hormone may better fit the need for coordinated regulation of these multiple effects in VSMCs than the circulating vitamin, which is regulated entirely by systemic calcium homeostatic factors. Indeed, a recent publication indicated that 25(OH)D 3 -1␣-hydroxylase is expressed in endothelial cells, 17 in which it appears to modulate cell growth 17, 18 and increase monocyte adhesion. 18 Given the high circulating levels of 25(OH)D 3 , the precursor of 1,25(OH) 2 D 3 , we reasoned that a locally expressed 25(OH)D 3 -1␣-hydroxylase system might enable VSMCs to regulate the concentrations of 1,25(OH) 2 D 3 in an autocrine and/or paracrine manner so that it can be governed by local factors and provide intracellular ligands for the VSMC vitamin D receptor. In the present study, we show that functional 25(OH)D 3 -1␣-hydroxylase is indeed expressed in cultured human VSMCs and that it can be regulated by parathyroid hormone (PTH) and by several estrogenic compounds.
Methods

Cell Culture
VSMCs were prepared from human umbilical artery as previously described with minor modifications. 19, 20 In brief, umbilical cords were collected shortly after delivery, and arteries were dissected, cleaned of blood and adventitia, and cut into tiny slices (1 to 3 mm). The segments were kept in culture in medium 199 containing 20% FCS, glutamine, and antibiotics. Cell migration was detected within 5 to 7 days. Cells were fed twice a week; on confluence, they were trypsinized and transferred to 24-well dishes. Cells were used only at passages 1 through 3 when expression of smooth muscle actin was clearly demonstrable.
25-Hydroxyvitamin D 3 -1␣-Hydroxylase mRNA Expression in VSMCs
Total RNA from cultured VSMCs was extracted with the Trizol Reagent (Gibco). An aliquot of 1 g RNA from each sample was reverse transcribed (RT) with the Advantage RT for polymerase chain reaction (PCR) kit (Clonthec), as previously described. 19 25(OH)D 3 -1␣-OH-hydroxylase mRNA levels were analyzed with the ABI 7700 sequence detection system. Amplification of its cDNA was performed in 25 L on 96-well plates in a reaction buffer containing Taqman universal PCR master mixture. The sequences of nucleotides were as follows: forward primer, CACCCGACACG-GAGACCTT; reverse primer, TCAACAGCGTGGACACAAACA; and Taqman probe, TCCGCGCTGTGGGCTCGG. RnaseP expression served as an internal control for each sample and was performed by assay-on-demand gene expression products, which consist of a ϫ20 mixture of unlabeled PCR primers and Taqman MGB probe labeled with 5Ј carboxy fluorescein dye. Measurements were performed in triplicate. The PCR conditions were as follows: 50°C for 2 minutes, 95°C for 10 minutes, 50 cycles of 95°C for 15 seconds, and 60°C for 1 minute. The total volume of the reaction was 25 L: 12.5 L universal master mix, 1.25 L ϫ20 assay-on-demand mix, and 11.25 L cDNA. 
Assessment of 25-Hydroxyvitamin
Preparation of Estradiol Macromolecular Conjugates
Estradiol-6-(O)-carboxymethyl oxime (E 2 -6-CMO) 21 was prepared by conjugating E 2 to carboxymethylamine hemihydrochloride. The nature of the conjugate was confirmed by thin-layer chromatography. 21 E 2 -6-CMO was conjugated to ovalbumin (Ov) via a 2-step reaction as described previously. 21, 22 In the first step, E 2 -6-CMO was conjugating in dry dioxane with N-hydroxysuccinimide and carbodiimide. In the second step, the N-hydroxysuccinimide ester derivative of E 2 -6-CMO in dioxane was bound to Ov. Analysis of the compound indicated that it was free of E 2 -6-CMO and E 2 . 21 
Assessment of DNA Synthesis
Cells were grown until subconfluence and then treated with various hormones as indicated. Twenty-two hours later, [ 3 H] thymidine was added for 2 hours. Cells were then treated with 10% ice-cold trichloroacetic acid for 5 minutes and washed twice with 5% trichloroacetic acid and then with cold ethanol. The cellular layer was dissolved in 0.3 mL of 0.3N NaOH; samples were aspirated; and [
3 H] thymidine incorporation into DNA was determined. 8
Creatine Kinase Extraction and Assay
To compare the effect of the various hormones on growth with the more classic effects of E 2 , we measured creatine kinase (CK) brain-type specific activity, an established genomic response marker of E 2 . Cells were treated for 24 hours with the various hormones as specified and were then scraped off the culture dishes and homogenized by freezing and thawing 3 times in an extraction buffer as previously described. 8 Supernatant extracts were obtained by centrifugation of homogenates at 14 000g for 5 minutes at 4°C in an Eppendorf microcentrifuge. CK activity was assayed by a coupled spectrophotometric assay described previously. 8 Protein was determined by Coomasie blue dye binding with BSA as the standard.
Statistical Analysis
Differences between the mean values obtained from the experimental and control groups were evaluated by ANOVA. A value of PϽ0.05 was considered significant. (Figure 1 ). When VSMCs were incubated for 60 minutes with increasing concentrations of 25(OH)D 3 ranging from 10 ng/mL to 500 ng/mL, the concentrations of produced 1,25(OH) 2 D 3 increased dose dependently as a function of added 25(OH)D 3 , reaching a plateau at 200 ng/mL, with a Km of Ϸ25 ng/mL.
Results
Enzymatic Conversion of 25(OH)
D
Effect of PTH and Estrogenic Compounds on the Enzymatic Conversion of 25(OH)D 3 Into 1,25(OH) 2 D 3 in VSMCs
The effects of various agents on 25-hydroxyvitamin D 3 -1␣-hydroxylase activity were assessed by measuring the concentration of 1,25(OH) 2 We also examined the effects of several estrogenic compounds on 25-hydroxyvitamin D 3 -1␣-hydroxylase activity. In
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particular, we examined in detail the effect of genistein (Figure 2, top) , the best-studied phytoestrogen, and cBA ( Figure 2 , middle), a synthetic derivative of the isoflavone BA generated by the introduction of a carboxymethyl group at the 6 position of the isoflavone BA, because these compounds exhibit estrogenic properties 21, 23 and cannot be "aromatized" into an androgen. The effects of cBA and genistein on 25-hydroxyvitamin D 3 -1␣-hydroxylase activity are shown in Figures 3 and 4 . Both agents increased 1,25(OH) 2 D 3 synthesis in a dose-related manner. Of note is the steep rise induced by cBA at the nanomolar range, reaching a plateau at a cBA concentration of Ϸ6 nmol/L. Likewise, E 2 , BA, and cBA induced a significant increase in 25-hydroxyvitamin D 3 -1␣-hydroxylase activity when used at concentrations previously shown to maximally affect DNA synthesis and CK activity in this system of VSMCs. 21, 22 The observed increments in 1,25(OH) 2 D 3 concentration were 40Ϯ23% (PϽ0.05), 55ϩ13% (PϽ0.05), and 47Ϯ13% (PϽ0.05) for E 2 , BA, and genistein, respectively (Figure 3) . Additionally, the noncalcemic synthetic analog of 1,25(OH) 2 D 3 JKF also increased 1,25(OH) 2 D 3 production by 83Ϯ13% (PϽ0.01) (Figure 3) .
Because some of the effects of phytoestrogens on VSMC growth are exerted via membrane receptors, 24 we examined the effects of E 2 , cG, cD, and cBA either as free molecules or as conjugates to macroproteins incapable of traversing the cell membrane and E 2 -Ov, cG-Ov, cD-Ov, and cBA-Ov on 1,25(OH) 2 D 3 synthesis. As shown in Figure 4 , when conjugated to macroproteins, neither of these compounds (each eliciting an increase in production when incubated as a free hormone) was capable of affecting 1,25(OH) 2 D 3 production.
Expression of 25-Hydroxyvitamin D 3 -1␣-Hydroxylase mRNA in VSMCs
Using real-time PCR and the primers specified in Materials and Methods, we identified 25-hydroxyvitamin D 3 -1␣-hydroxylase mRNA expression in all RNA extracts of 7 different VSMC preparations tested. Furthermore, in cells treated daily (3 days) with PTH (1-84) (66 nmol/L), raloxifene (3 mol/L), genistein (3 mol/L), BA (3 mol/L), or cBA (0.03 mol/L), 25-hydroxyvitamin D 3 -1␣-hydroxylase mRNA increased by 43Ϯ13% (PϽ0.05), 176Ϯ28% (PϽ0.01), 65Ϯ11% (PϽ0.05), 152Ϯ24% (PϽ0.01), and 71Ϯ9% (PϽ0.05), respectively.
In contrast, the vitamin D analog JKF (1 nmol/L) or angiotensin II (not shown) had no effect on 25-hydroxyvitamin D 3 -1␣-hydroxylase mRNA expression (Figure 3) . 3 [H] thymidine incorporation into DNA (bottom) and on CK specific activity (top) in VSMCs. Cells were grown and incubated for 24 hours with various concentrations of 1,25(OH) 2 D 3 , and DNA synthesis and CK specific activity were assayed as described in Materials and Methods. Results are given as meanϮSEM (nϭ4) and are expressed as percent change from control 3 [H] thymidine incorporation or CK activity elicited by various treatments. Basal levels of 3 [H] thymidine incorporation into DNA in VSMCs was 18 982Ϯ3984 dpm/well; and specific activity of CK in control cells was 50.6Ϯ9. 8 38 Moreover, we report here that 1,25(OH) 2 D 3 inhibits VSMC cell growth and at the same time increases metabolic turnover as assessed by CK activity, thus underscoring the potential physiological implications of an intracellular 1,25(OH) 2 D 3 -generating system in these cells.
Discussion
That phytoestrogens can modulate 25-hydroxyvitamin D 3 -1␣-hydroxylase expression and activity in VSMCs is in accord with recent observations in human mammary and prostate cells in which genistein was shown to exert a concentration-dependent increase in the expression of this enzyme. 39, 40 It is also consistent with observations that estrogen increases circulating levels of 1,25(OH) 2 D 3 in postmenopausal women 41 and in pubertal girls, 42 although the mechanism underlying these in vivo changes remains unexplored. Of note, however, is the finding that the phytoestrogen derivatives, particularly cBA, were particularly potent in upregulating 25-hydroxyvitamin D 3 -1␣-hydroxylase expressions and activity. These observations add to the complexity of the known interactions of phytoestrogens in the vasculature. 43 Although the effects of all phytoestrogens tested here on 25-hydroxyvitamin D 3 -1␣-hydroxylase activity are stimulatory, the phytoestrogens exert diverse effects on cell growth; eg, BA and cBA increase DNA synthesis in VSMCs, and similar concentrations of genistein actually inhibit DNA synthesis in VSMCs. [21] [22] [23] 42 The increase in 25-hydroxyvitamin D 3 -1␣-hydroxylase activity induced by E 2 , cBA, and BA also requires the steroid molecule to enter the cell because it cannot be reproduced by the macroprotein conjugates of E 2 or the phytoestrogens that are incapable of traversing the cell membrane. Hence, these effects on 25-hydroxyvitamin D 3 -1␣-hydroxylase appear to be mediated through classic genomic effects. In contrast, some of the effects of phytoestrogens on growth can be elicited by the compounds in their conjugated form and thus are likely mediated through membrane-dependent pathways. 24 In conclusion, we provide the first evidence for the expression of an enzymatically active 25-hydroxyvitamin D 3 -1␣-hydroxylase system in human VSMCs that can be upregulated by PTH and by native and synthetic phytoestrogens. Because exogenous vitamin D inhibits VSMC proliferation, the potential role of this system as an autocrine mechanism to modulate VSMC growth and differentiation should be the subject of future investigation.
